GlaxoSmithKline Czech Republic made a net profit of CZK 65.4 mil in 2017, up 72% compared to the previous year. Historically, between 2003 and 2017, the company's net profit reached a high of CZK 240 mil in 2011 and a low of CZK -7.67 mil in 2006.
The result implies a return on equity of 4.30% and a return on invested capital of 5.87% in 2017. That is compared to an average of 6.49% and 6.67% over the last five years.
The company has been operating with average EBITDA margin of 2.92% in the last 5 years and an average net margin of 2.06%.
Since 2012, the firm's net profit increased by -60.1% or an average of -16.8% a year.
You can see all the company’s data at GlaxoSmithKline Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
